|Day's Range||38.93 - 40.19|
|52 Week Range||38.93 - 54.73|
|PE Ratio (TTM)||34.73|
|Dividend & Yield||0.30 (0.74%)|
|1y Target Est||N/A|
Dr. Reddy's Laboratories Ltd. (RDY) reported fourth-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 29 cents, down from 7 cents in the year-ago quarter.
On a per-share basis, the Hyderabad, India-based company said it had net income of 29 cents. The pharmaceutical posted revenue of $548 million in the period. For the year, the company reported profit of ...
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: